Abstract
Inflammation and hypersensitivity reactions are reactions of vascularized tissue to exogenous or endogenous noxa. Inflammation suggests a protective, immunologically or nonimmunologically mediated response that tends first to localize and then to neutralize noxious material. The inflammatory response is strictly intertwined with a complex series of events that serve to heal and repair the damaged tissue. However, inflammation and repair may be potentially harmful. Hypersensitivity reactions imply an incongruous or sustained activation of the immunologic reactions involved in the inflammatory response, which results not in protection, but in destruction of tissue integrity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Benveniste, J., Henson, P. M., and Cochrane, C. G. 1972, Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils and a platelet-activating factor, J. Exp. Med. 136:1356–1377.
Benveniste, J., Egido, J., and Gutierrez-Millet, V., 1976, Evidence for the involvement of the IgE-basophil system in acute serm sickness of rabbits, Clin. Exp. Immunol. 26:449–456.
Benveniste, J., Camussi, G., and Polonsky, I., Jr., 1977, Platelet-activating factor, Monogr. Allergy 12:138–142.
Benveniste, J., Tence, M., Varenne, P., Bidault, J., Boullet, C., and Polonsky, I., 1979, Semisynthèse et structure proposée du facteur activant les plaquettes (PAF): PAF-acether, un alkyl ether analogue de la lysophosphatidilcholine, C.R. Acad. Sci. (Paris) 289:1037–1040.
Benveniste, J., Boullet, C., Brink, C., and Labat, C., 1983, The actions of PAF-aceter (platelet-activating factor) on guinea pig isolated heart preparations, Br. J. Pharmacol. 80:81–85.
Bessin, P., Bonnet, J., Apffel, D., Soulard, C., Desgroux, L., Pelas, I., and Benveniste, J., 1983a, Acute circulatory collapse caused by platelet-activating factor (PAF-aceter) in dogs, Eur. J. Pharmacol. 86:403–413.
Bessin, P., Bonnet, J., Thibaudeon, J., Agier, B., Beand, Y., and Gilet, F., 1983b, Pathophysiology of shock states caused by PAF-acether in dogs and rats, in: Platelet Activating Factor ,INSERM Symposium No. 23 (J. Benveniste and B. Arnoux, eds.), Elsevier Science Publishers, Amsterdam, pp. 343–355.
Betz, S. J., Lotner, G. Z., and Henson, P. M., 1980, Generation and release of platelet-activating factor (PAF) from enriched preparations of rabbit basophils; failure of human basophils to release PAF, J. Immunol. 125:2749–2755.
Blank, M. L., Snyder, F., Byers, L. W., Brooks, B., and Muirhead, E., 1979, Anti-hypertensive activity of an alkyl ether analog of phosphatidylcholine, Biochem. Biophys. Res. Commun. 30:1134 -1200.
Burke, J. A., Levi, R., Hanahan, D. S., and Pinckard, R. M.. 1982, Cardiac effects of acetyl glyceryl ether phosphorylcholine (abstract), Fed. Proc. 41:823.
Bussolino, F., Foà , R., Malavasi, F., Ferrando, M., and Camussi, G., 1984, Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines, Exp. Hematol. 12:688–693.
Bussolino. F., Aglietta. M.. Sanavio, F., Stacchini, A.. Lauri, D., and Camussi, G., 1985. Alkyl-ether phosphoglycerides influence calcium fluxes into human endothelial cells, J. Immunol. 135:2748–2753.
Bussolino, F., Breviario, F., Tetta, C., Aglietta, M., Sanavio. F., Mantovani, A., and Dejana, E., 1986, Interleukin 1 stimulated platelet activating factor production in cultured human endothelial cells, J. Clin. Invest. 77:2027–2033.
Camussi, G., and Brentjens, J. R., 1985, Inhalation of horseradish peroxidase by rabbits with specific IgE antibodies results in release into the circulation of platelet-activating factor and in lung lesions, Clin. Immunol. Immunopathol. 34:333–344.
Camussi, G., Mencia-Huerta, J. M., and Benveniste, J., 1977, Release of platelet-activating factor and histamine. I. Effect of immune complexes, complement and neutrophils on human and rabbit mastocytcs and basophils, Immunology 33:523–534.
Camussi, G., Bosio, D., Segoloni, G., Tetta, C., and Vercellone, A., 1978, Evidence for the involvement of the IgE-basophil-mastocyte system in human acute post-streptococcal glomerulonephritis, Ric. Clin. Lab. 8:56–64.
Camussi, G., Bussolino, F., Tetta, C., Brusca, R., and Ragni, R., 1980, The binding of platelet-activating factor (PAF) to polymorphonuclear neutrophils (PMN) as a trigger of immune-induced PMN aggregation, Pan. Med. 22:1–5.
Camussi, G., Aglietta, M., Coda, R., Bussolino, F., Piacibello, W., and Tetta, C., 1981a, Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: Monocytes, polymorphonuclear neutrophils and basophils, Immunology 42:191–199.
Camussi, G., Montrucchio, G., Antro, C., Tetta, C., Ragni, R., and Emanuelli, G., 1981b, In vitro spasmogenic effect of platelet-activating factor on rabbit lung tissue, Pan. Med. 23:179–184.
Camussi, G., Tetta, C., Bussolino, F., Caligaris-Cappio, F., Masera, C., and Segoloni, G., 1981c, Mediators of immune complex induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation, Int. Arch. Allergy Appl. Immunol. 64:25–41.
Camussi, G., Tetta, C., Ghezzo, F., and Pegoraro, L., 1981 d, Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation, Blood 59:16–22.
Camussi, G., Tetta, C., Deregibus, M. C., Bussolino, F., Segoloni, G., and Vercellone, A., 1982, Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: Role of basophil-derived PAF in immune complex deposition, J. Immunol. 128:86–94.
Camussi, G., Aglietta, M., Malavasi, F., Tetta, C., Piacibello, W., Sanavio, F., and Bussolino, F., 1983a, The release of platelet-activating factor from human endothelial cells in culture, J. Immunol. 131:2397–2403.
Camussi, G., Arese, P., Tetta, C., Bussolino, F., Coda, R., and Vercellone, A., 1983b, Platelet activating factor, in: Glomerular Injury 300 Years after Morgagni (T. Bertani and G. Remuzzi, eds.), Wichting, Milano, pp. 89–118.
Camussi, G., Bussolino, F., Tetta, C., Piacibello, W., and Aglietta, M., 1983c, Biosynthesis and release of platelet-activating factor from human monocytes, Int. Arch. Allergy Appl. Immunol. 70:245–251.
Camussi, G., Pawlowski, I., Bussolino, F., Caldwell, P., Brentjens, J., and Andres, G., 1983d, Release of platelet-activating factor in rabbits with antibody mediated injury of the lung. The role of polymorphonuclear neutrophils and pulmonary endothelial cells, J. Immunol. 131:1802–1806.
Camussi, G., Tetta, C., and Bussolino, F., 1983e, Inhibitory effect of prostacyclin (PGI2) on neutropenia induced by intravenous injection of platelet-activating factor (PAF) in the rabbit, Prostaglandins 25:343–351.
Camussi, G., Pawlowski, I., Tetta, C., Roffinello, C., Alberton, M., Brentjens, J., and Andres, G., 1983f, Acute lung inflammation induced in the rabbit by local instillation of l-O-octadecyl-2-acetyl-sn-glycery 1–3-phosphorylcholine or of native platelet activating factor, Am. J. Pathol. 112:78–88.
Camussi, G., Alloatti, G., Montrucchio, G., Meda, M., and Emanuelli, G., 1984a, Effect of platelet-activating factor on guinea pig papillary muscle, Experientia 40:697–699.
Camussi, G., Tetta, C., Coda, R., Segoloni, G., and Vercellone, A., 1984b, Platelet activating factor-induced loss of glomerular anionic charges, Kidney Int. 25:73–81.
Chignard, M., LeCouedic, J. P., Tence, M., Vargaftig, B. B., and Benveniste, J., 1979, The role of platelet-activating factor in platelet aggregation, Nature 279:799–800.
Demopoulos, C. A., Pinckard, R. N., and Hanahan, D. J., 1979, Platelet-activating factor. Evidence for l-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (A new class of lipid chemical mediators), J. Biol. Chem. 254:9355–9358.
Doebber, T. W., Wu, M. S., Robbins, J. C., Choy, B. M., Chang, M. N., and Shen, T. Y., 1985, Platelet activating factor (PAF) involvement in endotoxin induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone, Biochem. Biophys. Res. Commun. 127:799–808.
Findley, S. R., Lichtenstein, L. M., Hanahan, D. J., and Pinckard, R. N., 1981, The contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine, Am. J. Physiol. 241:C130–133.
Halonen, M., Palmer, J. D., Lohman, I. C., McManus, L. M., and Pinckard, R. N., 1980, Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine (AGEPC) a mediator of IgE anaphylaxis in the rabbit, Am. Rev. Resp. Dis. 122:915–924.
Halonen, M., Palmer, J. D., Lohman, I. C., McManus, L. M., and Pinckard, R. N., 1981, Differential effects of platelet depletion on the cardiovascular and pulmonary alterations of IgE anaphylaxis and AGEPC infusion in the rabbit, Am. Rev. Resp. Dis. 124:416–421.
Handley, D. A., Van Valen, R. G., Melden, M. K., Flury, S., Lee, M. L., and Saunders, R. N., 1986, Inhibition and reversal of endotoxin-aggregated IgG and PAF-induced hypotension in the rats by SRI 63072, a PAF receptor antagonist, Immunopharmacology 12:11–16.
Hellewell, P. G., and Williams, T. J., 1986, A specific antagonist of platelet-activating factor suppresses oedema formation in an Arthus reaction but not oedema induced by leukocyte chemoattractants in rabbit skin, J. Immunol. 137:302–307.
Henson, P. M., and Cochrane, C. G., 1971, Acute immune complex disease in rabbits. The role of complement and of a leukocyte-dependent release of vasoactive amines from platelets, J. Exp. Med. 133:554–571.
Henson, P. M., and Pinckard, R. N., 1977, Basophil derived platelet-activating factor (PAF) as an in vivo mediator of acute allergic reactions. Demonstration of specific desensitization of platelets to PAF during IgE-induced anaphylaxis in the rabbit, J. Immunol. 119:2179–2184.
Humphrey, D. M., Hanahan, D. J., and Pinckard, R. N., 1982a, Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine, Lab. Invest. 47:227–234.
Humphrey, D. M., McManus, L., Satouchi, K., Hanahan, D. J., and Pinckard, R. N., 1982b, Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogs, Lab. Invest. 46:422–427.
Humphrey, D. M., McManus, L., Hanahan, D. J., and Pinckard, R. N., 1984, Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine, Lab. Invest. 50:16–25.
Issekutz, A. C., and Szejda, M., 1986, Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet activating factor antagonist, CV 3988, Lab. Invest. 54:275–281.
Ito, S., Camussi, G., Tetta, C., Milgrom, F., and Andres, G., 1984, Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets, Lab. Invest. 51:148–161.
Lewis, T. (ed.), 1927, The Blood Vessels of the Human Skin and Their Responses ,Shaw, London.
Lotner, G. Z., Lynch, J. M., Betz, S. J., and Henson, P. M., 1980, Human neutrophil-derived platelet activating factor, J. Immunol. 124:676–684.
Lynch, J. M., Lotner, G. Z., Betz, S. J., and Henson, P. M., 1979, The release of platelet-activating factor by stimulated rabbit neutrophils, J. Immunol. 123:1219–1226.
Majno, G., 1982, Inflammation and infection. Historical highlights, in: Current Topics in Inflamation and Infection (G. Majno and R. S. Cotran, eds.), Williams and Wilkins, Baltimore, p. 1.
McIntyre, T. M., Zimmerman, G. A., Satoh, K., and Prescott, S. M., 1985, Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate, J. Clin. Invest. 76:271–278.
McManus, L., and Pinckard, R. N., 1985, Kinetics of acetyl glyceryl ether phosphorylcholine (AGEPC)-induced acute lung alterations in the rabbit, Am. J. Pathol. 121:55–68.
McManus, L. M., Hanahan, D. J., Demopoulos, C. A., and Pinckard, R. N., 1980, Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC) a synthetic platelet activating factor (PAF) in the rabbit, J. Immunol. 124:2919–2924.
McManus, L. M., Pinckard, R. N., Fitzpatrick, F. A., O’Rourke, R. A., Drawford, M. H., and Hanahan, D. J., 1981. Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon, Lab. Invest. 45:303–307.
Mencia-Huerta, J. M., and Benveniste, J., 1979, Platelet activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes, Eur. J. Immunol. 9:409–415.
Mencia Herta, J., Lewis, R. A., Razin, E., and Austin, K. F., 1983, Antigen initiated release of platelet activating factor (PAF-acether) from bone marrow-derived mast-cells sensitized with monoclonal IgE, J. Immunol. 131:2958–2964.
Muirhead, E. E., Byers, L. N., Desiderio, D. M., Brooks, B. B., and Brosius, W. M., 1981, Antihypertensive lipids from the kidney: Alkyl ether analogs of phosphatidylcholine, Fed. Proc. 40:2285–2290.
O’Flaherty, J. R., Wykle, R. L., Miller, C. H., Lewis, J. C., Waite, M., Bass, D. A., McCall, C. E., and DeChatelet, L. R., 1981, l-0-alkyl-sn-glyceryl-3-phosphorylcholine: A novel class of neutrophil stimulants, Am. J. Pathol. 103:70.
Pinckard, R. N., Farr, R. S., and Hanahan, D. J., 1979, Physicochemical and functional identity of rabbit platelet activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE-sensitized basophils, J. Immunol. 123:1847–1857.
Pinckard, R. N., Kniker, W. T., Lee, L., Hanahan, D. J., and McManus, L. M., 1980, Vasoactive effect of l-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (AcGEPC) in human skin (abstract), J. Allergy Clin. Immunol. 65:196.
Prescott, S. M., Zimmerman, G. A., and McIntyre, T. M., 1984, Human endothelial cells in culture produce platelet-activating factor (l-alkyl-2-acetyl-sn-glyceryl-3-phosphocholine) when stimulated with thrombin, Proc. Natl. Acad. Sci. USA 81:3534–3538.
Sanchez-Crespo, M., Alonso, F., and Egido, J., 1980, Platelet activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclear neutrophils and monocytes during the stimulation by ionophore A 23187 and phagocytosis and not from degranulating basophils, Immunology 40:645–655.
Sanchez-Crespo, M., Alonso, F., Inarrea, P., Alvarez, V., and Egido, J., 1982, Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: Evidence for a platelet independent mechanism, Immunopharmacology 4:173–185.
Schlondorff, D., Satriano, J. A., Hagage, J., Perez, J., and Baund, L., 1984, Effect of platelet-activating factor (PAF) and serum treated zymosan (STZ) on PGE2 synthesis, arachidonic acid (AA) release and contraction of cultured rat mesangial cells (abstract), Kidney Int. 25:336.
Schreiner, G. F., and Unanue, E. R., 1976, Membrane and cytoplasmic changes in B lymphocytes induced by ligand-surface immunoglobulin interaction, in: Advances in Immunology (F. J. Dixon and H. G. Kunkel, eds.), Academic Press, New York, pp. 37–58.
Shaw, J. O., Pinckard, R. N., Ferrigni, K. S., McManus, L., and Hanahan, D. J., 1981, Activation of human neutrophils with l-0-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor), J. Immunol. 127:1250–1255.
Siraganian, R. P., and Osier, A. G., 1971, Destruction of rabbit platelets in the allergic response of sensitized leukocytes. II. Evidence of basophil involvement, J. Immunol. 106:1252–1262.
Stimler, N. P., Bloor, C. M., Hugli, T. E., Wykle, R. L., McCall, C. E., and O’Flaherty, J. R., 1981, Anaphylactic actions of platelet activating factor, Am. J. Pathol. 105:64–69.
Vargaftig, B. B., Lefort, J., Chignard, M., and Benveniste, J., 1980, Platelet activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives, Eur. J. Pharmacol. 65:185–192.
Worthen, G. S., Goins, A. J., Mitchel, B. C., Larsen, G. L., Reeves, J. R., and Henson, P. M., 1983, Platelet-activating factor causes neutrophil accumulation and edema in rabbit lungs, Chest (Suppl.) 83:13S–15S.
Yasaka, T., Boxer, L. A., and Baehner, R. L., 1982, Monocyte aggregation and superoxide anion release in response to formylmethionyl-leucyl-phenyalanine (FMLP) and platelet activating factor (PAF), J. Immunol. 128:1939–1944.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Camussi, G., Brentjens, J.R. (1987). The Role of Platelet-Activating Factor in Inflammation. In: Snyder, F. (eds) Platelet-Activating Factor and Related Lipid Mediators. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5284-6_14
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5284-6_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5286-0
Online ISBN: 978-1-4684-5284-6
eBook Packages: Springer Book Archive